Effects of Acute Hypervolaemic Haemodilution on the Expression of Plasma Interferon-Inducible Protein-10 and Bactericidal/Permeability-Increasing Protein in Patients Undergoing Total Hip Replacement

Abstract

This prospective, randomized controlled study evaluated the effects of acute hypervolaemic haemodilution (AHH) on the expression of plasma interferon-inducible protein-10 (IP-10) and bactericidal/permeability-increasing protein (BPI) in patients undergoing elective total hip replacement. Twenty patients were randomized to receive an infusion of either hydroxyethyl starch (HES group) or lactated Ringer's solution (LR group) immediately after anaesthesia. Plasma concentrations of IP-10 and BPI were measured before anaesthesia (baseline), at the start of surgery, 30 min after the start of surgery and at the end of surgery. Blood loss and the volume of blood transfused were significantly lower in the HES group compared with the LR group. Compared with baseline, IP-10 and BPI concentrations increased significantly in both groups 30 min after the start of surgery. The IP-10 concentrations were significantly lower and BPI concentrations significantly higher in the HES group compared with the LR group 30 min after the start of surgery and at the end of surgery. It is concluded that AHH with HES may be helpful in ameliorating immune function during total hip replacement and in reducing blood loss and the extent of blood transfusion.

Keywords

Total hip replacement Haemodilution Chemokine Immunomodulator Interferon-inducible protein-10 (IP-10)Bactericidal/permeability-increasing protein (BPI)

References

Mielke

Entholzner

Kling

: Preoperative acute hypervolemic hemodilution with hydroxyethylstarch: An alternative to acute normovolemic hemodilution? Anesth Analg 1997; 84: 26–30.

Callaghan

Spitzer

: Blood management and patient specific transfusion options in total joint replacement surgery. Iowa Orthop J 2000; 20: 36–45.

Ickx

Bepperling

Melot

: Plasma substitution effects of a new hydroxyethyl starch HES 130/0.4 compared with HES 200/0.5 during and after extended acute normovolaemic haemodilution. Br J Anaesth 2003; 91: 196–202.

Trouwborst

van Woerkens

Tenbrinck

: Acute hypervolaemic haemodilution to avoid blood transfusion during major surgery. Lancet 1990; 336: 1295–1297.

Tang

Q-F

Qian

Y-N

Qiu

Y-H

: Effects of preemptive intravenous lornoxicam on the analgesic efficacy of epidural morphine and expression of chemokines in women undergoing hysterectomy. Curr Ther Res 2009; 70: 1–9.

Bauer

Rensing

Ziegenfuss

: Anesthesia and perioperative immune function. Anaesthesist 1998; 47: 538–556 [in German].

Browne

Birnbach

Stein

: A comparison of Espocan® and Tuohy needles for the combined spinal-epidural technique for labor analgesia. Anesth Analg 2005; 101: 535–540.

Padovan

Spagnoli

Ferrantini

: IFN-α2a induces IP-10/CXCL10 and MIG/CXCL9 production in monocyte-derived dendritic cells and enhances their capacity to attract and stimulate CD8+ effector T cells. J Leukoc Biol 2002; 71: 669–676.

Lee

Takemoto

Kurata

: GATA-3 induces T helper cell type 2 (Th2) cytokine expression and chromatin remodeling in committed Th1 cells. J Exp Med 2000; 192: 105–116.

10.

Marchant

Goldman

: T cell-mediated immune responses in human newborns: Ready to learn? Clin Exp Immunol 2005; 141: 10–18.

11.

Ranjbaran

Wang

Manes

: Heparin displaces interferon-γ-inducible chemokines (IP-10, I-TAC, and Mig) sequestered in the vasculature and inhibits the transendothelial migration and arterial recruitment of T cells. Circulation 2006; 114: 1293–1300.

12.

Høgevold

Lyberg

Kähler

: Changes in plasma IL-1β, TNF-α and IL-6 after total hip replacement surgery in general or regional anaesthesia. Cytokine 2000; 12: 1156–1159.

13.

Schultz

Weiss

Carroll

: The endotoxin-binding bactericidal/permeability-increasing protein (BPI): A target antigen of autoantibodies. J Leukoc Biol 2001; 69: 505–512.

14.

Yao

Bahrami

Leichtfried

: Pathogenesis of hemorrhage-induced bacteria/endotoxin in translocation in rats. Effects of recombinant bactericidal/permeability-increasing protein. Ann Surg 1995; 221: 398–405.

15.

Monajemi

: Inflammatory bowel disease is associated with increased mucosal levels of bactericidal/permeability-increasing protein. Gastroenterology 1996; 110: 733–739.

16.

Niemi

Suojaranta-Ylinen

Kukkonen

: Gelatin and hydroxyethyl starch, but not albumin, impair hemostasis after cardiac surgery. Anesth Analg 2006; 102: 998–1006.

17.

Kaplan

Park

Gonzales

: Hydroxyethyl starch reduces leukocyte adherence and vascular injury in the newborn pig cerebral circulation after asphyxia. Stroke 2000; 31: 2218–2223.

18.

Tian

Lin

Zhou

: Hydroxyethyl starch inhibits NF-κB activation and prevents the expression of inflammatory mediators in endotoxic rats. Ann Clin Lab Sci 2003; 33: 451–458.

19.

Tian

Lin

Guan

: The effects of hydroxyethyl starch on lung capillary permeability in endotoxic rats and possible mechanisms. Anesth Analg 2004; 98: 768–774.

20.

Zhou

: Hydroxyethyl starch exhibits antiinflammatory effects in the intestines of endotoxemic rats. Anesth Analg 2006; 103: 149–155.

21.

Vogt

Bothner

Lerch

: Large-dose administration of 6% hydroxyethyl starch 200/0.5 total hip arthroplasty: Plasma homeostasis, hemostasis, and renal function compared to use of 5% human albumin. Anesth Analg 1996; 83: 262–268.

22.

Hiki

Berger

Dentener

: Changes in endotoxin-binding proteins during major elective surgery: Important role for soluble CD14 in regulation of biological activity of systemic endotoxin. Clin Diag Lab Immunol 1999; 6: 844–850.